Cash and Cash Equivalents, at Carrying Value of KESTRA MEDICAL TECHNOLOGIES, LTD. from 30 Apr 2024 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Apr 2024 to 31 Jan 2026.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Jan 2026 was $291,321,000, a 436% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $291,321,000 +$236,969,000 +436% 31 Jan 2026 10-Q 17 Mar 2026 2026 Q3
Q3 2025 $175,424,000 +$98,506,000 +128% 31 Oct 2025 10-Q 11 Dec 2025 2025 Q2
Q2 2025 $201,214,000 +$101,245,000 +101% 31 Jul 2025 10-Q 12 Sep 2025 2025 Q1
Q1 2025 $237,595,000 +$229,346,000 +2780% 30 Apr 2025 10-Q 17 Mar 2026 2026 Q3
Q4 2024 $54,352,000 31 Jan 2025 10-Q 17 Mar 2026 2026 Q3
Q3 2024 $76,918,000 31 Oct 2024 10-Q 11 Dec 2025 2025 Q2
Q2 2024 $99,969,000 31 Jul 2024 10-Q 12 Sep 2025 2025 Q1
Q1 2024 $8,249,000 30 Apr 2024 10-K 17 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.